At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from rare diseases.
Our internal drug repositioning engine, NexusRx, serves as a cornerstone for our discovery research, employing internal sets of proprietary algorithms to detect unknown and unforeseen relationships between disease-targets-drugs. This opens up preclinical validation opportunities which we perform in close partnerships with our academic collaborators. We envision to perform clinical trials and bring therapeutics from lab to bed side.
Introducing Our Fully-Integrated Drug Discovery Framework- NexusRx
Unified data umbrella: Seamlessly generate insights from over 25+ sources, including clinical trials, publications, omics datasets, patents, anonymized patient datasets (proprietary) and other specialized databases (internal and external).
Navigating the Disease Landscape: Generate comprehensive network models that visualize disease progression and drug interactions at the molecular level.
Exploring Hidden Connections: Find correspondence between networks to to identify promising drug-disease matches that might have been missed.
Expansion of Treatment Options: Uncover novel uses for existing medications based on their interaction with disease pathways and pharmacological actions.
Accelerate Drug Development: Pinpoint promising drug leads with high potential for further development.
Optimize Clinical Trials: Clinical endpoint mapping and adverse events mapping facilitates identification of potential biomarkers that can streamline drug development by analyzing previous treatment response in patients.